Northern Ireland is grappling with an unprecedented surge in cancer diagnoses, with approximately 10,700 individuals diagnosed annually – a stark figure translating to about 29 new cases each day. This marks a record high for the region. Concurrently, Cancer Research UK highlights that cancer remains the leading cause of death, claiming around 4,600 lives each year.
The escalating number of diagnoses arrives as waiting lists for diagnosis and treatment remain persistently problematic, with official figures showing a consistent failure to meet crucial targets. Data covering October to December 2024, released by the Northern Ireland Statistics and Research Agency (NISRA), revealed that only one-third of "red-flagged" patients commenced their first definitive treatment within the stipulated 62-day window. Specifically, only 403 out of 1,239 such patients started treatment within this timeframe.
This critical shortfall impacts all Health and Social Care Trusts, with none meeting the 62-day target. The situation is mirrored in the 14-day target for urgent breast cancer referrals, a benchmark also missed across the region. Performance figures for April to June 2025 also indicated a failure to meet key targets, with one report describing the performance as the "third worst on record."
Read More: Katie Couric Shares Protein Reese's Recipe
Persistent Delays and Their Consequences
The extended waiting periods are not merely statistical anomalies; they translate into tangible distress and potentially poorer outcomes for patients. Individuals describe the wait for a diagnosis as "awful," with concerns that longer delays exacerbate existing anxieties, particularly for those with a family history of cancer. Experts warn that prolonged waits can lead to missed opportunities for certain treatments or patients becoming too unwell to undergo them, thereby diminishing survival chances.
"It’s unacceptable that people are still waiting too long for a diagnosis and treatment, something which causes real distress," remarked Liz Morrison, public affairs manager for Cancer Research UK in Northern Ireland. She stressed that such delays may lead to patients missing crucial treatment windows or becoming too sick to benefit, impacting survival rates.
Data Challenges and Systemic Issues
Recent statistics have been complicated by the introduction of the 'encompass' patient record system, a transition that has led to data comparability issues and a lack of detailed Trust-by-Trust breakdowns for certain periods. This has made a complete picture of breast cancer referral performance challenging to ascertain for specific quarters.
The Department of Health acknowledged these data revisions, noting that target data for HSC Trusts have been altered due to the ongoing development and evaluation of the 'encompass' system.
Despite these data challenges, the consistent missing of targets has drawn sharp criticism. Remarks such as "unacceptable" and "scandalous" have been used to describe the current waiting times, with calls for cancer treatment to be made a top priority by the Northern Ireland Executive.
Read More: Northern Ireland: 10,700 Cancer Cases Yearly, Services Strained
Background
Cancer Research UK has repeatedly urged the Northern Ireland Executive to prioritize tackling waiting lists. Cancer has been identified as the leading cause of death in the region, underscoring the urgency of addressing these diagnostic and treatment delays. The statistics agency NISRA regularly publishes accredited official statistics on cancer waiting times, measuring performance against targets such as the 31-day standard (98% of diagnosed patients receiving first definitive treatment within 31 days of decision to treat) and the 14-day breast cancer referral target. The implementation of the 'encompass' system, while intended to improve patient record management, has introduced complexities in the timely reporting and analysis of waiting times data.
